Patents by Inventor Cyril Chaput

Cyril Chaput has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160101214
    Abstract: The present invention relates to a minimally-invasive method for restoring a damaged or degenerated intevertebral disc at an early stage. The method comprises the step of administering an injectable in situ setting formulation in the nucleus pulposus of the damaged or degenerated disc of the patient. The formulation once injected combines with nucleus matters and host cells, and becomes viscous or gels in situ within the annulus fibrosus of the disc for increasing the thickness and volume of the damaged or degenerated disc. The formulation is retained within the disc for providing restoration of the damaged or degenerated disc.
    Type: Application
    Filed: December 17, 2015
    Publication date: April 14, 2016
    Applicant: PIRAMAL HEALTHCARE (CANADA) LTD.
    Inventors: Eric Andre DESROSIERS, Abdellatif CHENITE, Mohammed BERRADA, Cyril CHAPUT
  • Patent number: 8920842
    Abstract: The present invention relates a biopolymeric liquid aqueous composition for producing self-gelling systems and gels, which comprises: an acidic water-based medium, 0.1 to 10% by weight of a pH-gelling acid-soluble biopolymer; and 0.1 to 10% by weight of a water-soluble molecule having a basic character and a pKa between 6.0 and 8.4, or a water-soluble residue or sequence of the molecule having a basic character and a pKa between 6.0 and 8.4. The liquid composition has a final pH ranging from 5.8 and 7.4, and forms a stable solid and homogeneous gel within a temperature range from 10 to 70° C. The present invention also relates to a method for preparing the composition and uses thereof.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: December 30, 2014
    Assignee: Piramal Healthcare (Canada) Ltd.
    Inventors: Abdellatif Chenite, Cyril Chaput, Dong Wang, Amine Selmani
  • Patent number: 8747899
    Abstract: Self-forming hybrid compositions consisting in admixed liquid and solid components enable the formation of bio-materials. The present invention proposes a) a thermo-sensitive self-forming liquid component, being water-based and containing at least a polycationic polymer such as chitosan, and an organic mono-phosphate source, which is a solution at a pH ranging from 6.5 to 7.4; b) a solid component being mineral and composed of at least one of calcium, fluoride, strontium, carbonate and phosphate salts. Solid mineral salts preferentially have a recognized bioactive potential such as the calcium phosphate salts for bones. Both solid and liquid components are admixed to form an injectable liquid slurry or pre-gelled paste that turn in situ into a hybrid uniform gel-like bio-material.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: June 10, 2014
    Assignee: Piramal Healthcare (Canada) Ltd.
    Inventors: Cyril Chaput, Abdellatif Chenite
  • Patent number: 8389467
    Abstract: The present invention relates to self-setting compositions consisting in admixed liquid and solid components enable the formation of hardened bio-materials having a broad range of properties and performances. The present invention proposes a) a thermo-sensitive self-gelling liquid component, being water-based, comprising at least a polycationic and a phosphate source, wherein the liquid component is a thermo-gelling solution at a pH ranging from 6.5 to 7.4; b) a powder component consisting in at least two calcium phosphate sources. The preferred calcium phosphate source includes apatites, tricalcium phosphates, tetracalcium phosphates and dicalcium phosphates. Both solid and liquid components are admixed to form a flowable slurry that sets in situ into a hardened calcium phosphate based bio-material.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: March 5, 2013
    Assignee: Piramal Healthcare (Canada) Ltd.
    Inventors: Cyril Chaput, Anabelle Rodrigues El Zein
  • Publication number: 20100029549
    Abstract: The present invention relates to self-setting compositions consisting in admixed liquid and solid components enable the formation of hardened bio-materials having a broad range of properties and performances. The present invention proposes a) a thermo-sensitive self-gelling liquid component, being water-based, comprising at least a polycationic and a phosphate source, wherein the liquid component is a thermo-gelling solution at a pH ranging from 6.5 to 7.4; b) a powder component consisting in at least two calcium phosphate sources. The preferred calcium phosphate source includes apatites, tricalcium phosphates, tetracalcium phosphates and dicalcium phosphates. Both solid and liquid components are admixed to form a flowable slurry that sets in situ into a hardened calcium phosphate based bio-material.
    Type: Application
    Filed: October 8, 2009
    Publication date: February 4, 2010
    Applicant: BIOSYNTECH CANADA INC.
    Inventors: Cyril Chaput, Anabelle Rodrigues El Zein
  • Publication number: 20100028434
    Abstract: The present invention relates a biopolymeric liquid aqueous composition for producing self-gelling systems and gels, which comprises: an acidic water-based medium, 0.1 to 10% by weight of a pH-gelling acid-soluble biopolymer; and 0.1 to 10% by weight of a water-soluble molecule having a basic character and a pKa between 6.0 and 8.4, or a water-soluble residue or sequence of the molecule having a basic character and a pKa between 6.0 and 8.4. The liquid composition has a final pH ranging from 5.8 and 7.4, and forms a stable solid and homogeneous gel within a temperature range from 10 to 70° C. The present invention also relates to a method for preparing the composition and uses thereof.
    Type: Application
    Filed: October 9, 2009
    Publication date: February 4, 2010
    Applicant: BIO SYNTECH CANADA, INC.
    Inventors: Abdellatif Chenite, Cyril Chaput, Dong Wang, Amine Selmani
  • Publication number: 20100021545
    Abstract: Self-forming hybrid compositions consisting in admixed liquid and solid components enable the formation of bio-materials. The present invention proposes a) a thermo-sensitive self-forming liquid component, being water-based and containing at least a polycationic polymer such as chitosan, and an organic mono-phosphate source, which is a solution at a pH ranging from 6.5 to 7.4; b) a solid component being mineral and composed of at least one of calcium, fluoride, strontium, carbonate and phosphate salts. Solid mineral salts preferentially have a recognized bioactive potential such as the calcium phosphate salts for bones. Both solid and liquid components are admixed to form an injectable liquid slurry or pre-gelled paste that turn in situ into a hybrid uniform gel-like bio-material.
    Type: Application
    Filed: October 8, 2009
    Publication date: January 28, 2010
    Applicant: BIOSYNTECH CANADA INC.
    Inventors: Cyril Chaput, Abdellatif Chenite
  • Publication number: 20090030525
    Abstract: The present invention relates to a minimally-invasive method for restoring a damaged or degenerated intervertebral disc at an early stage. The method comprises the step of administering an injectable in situ setting formulation in the nucleus pulposus of the damaged or degenerated disc of the patient. The formulation once injected combines with nucleus matters and host cells, and becomes viscous or gels in situ within the annulus fibrosus of the disc for increasing the thickness and volume of the damaged or degenerated disc. The formulation is retained within the disc for providing restoration of the damaged or degenerated disc.
    Type: Application
    Filed: August 4, 2008
    Publication date: January 29, 2009
    Applicant: BIO SYNTECH CANADA, INC.
    Inventors: Eric Andre DESROSIERS, Abdellatif CHENITE, Mohammed BERRADA, Cyril CHAPUT
  • Patent number: 7098194
    Abstract: In accordance with the present invention there is provided a new composition and method for chemically modifying chitosan, including N-substituting or N-cross-linking, under homogeneous conditions by providing neutral aqueous chitosan solutions with enhanced reactivity. The method comprises the steps of i) preparing a clear aqueous solution of chitosan, said solution comprising 0.1 to 10% by weight of a chitosan, and 0.1 to 20% by weight of at least one buffering agent having a pKa between 6.0 and 7.6, said solution having a pH ranging from 6.8 to 7.2; and ii) dissolving homogeneously at least one reagent into the solution of step a), said reagent being reactive toward amine groups of chitosan; and said reagent being at a concentration from 0.01 to 10% by weight. The chitosan in the aqueous solution is chemically modified or cross-linked by a selective substitution on the amino group of chitosan.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: August 29, 2006
    Assignee: Biosyntech Canada, Inc.
    Inventors: Abdellatif Chenite, Mohammed Berrada, Cyril Chaput, Fouad Dabbarh, Amine Selmani
  • Publication number: 20040091540
    Abstract: The present invention relates to a minimally-invasive method for restoring a damaged or degenerated intervertebral disc at an early stage. The method comprises the step of administering an injectable in situ setting formulation in the nucleus pulposus of the damaged or degenerated disc of a patient. The formulation once injected combines with nucleus matters and host cells, and becomes viscous or gels in situ within the annulus fibrosus of the disc for increasing the thickness and volume of the damaged or degenerated disc. The formulation is retained within the disc for providing restoration of the damaged or degenerated disc.
    Type: Application
    Filed: December 15, 2003
    Publication date: May 13, 2004
    Inventors: Eric Andre Desrosiers, Abdellatif Chenite, Mohammed Berrada, Cyril Chaput
  • Publication number: 20040047892
    Abstract: The present invention relates to a filler composition for soft-tissue augmentation and reconstructive surgery comprising an effective amount of an injectable thermo-gelling solution comprising 0.1 to 5.0% by weight of chitosan or collagen or a derivative thereof; and 1.0 to 20% by weight of a salt of polyol or sugar selected from the group consisting of mono-phosphate dibasic salt, mono-sulfate salt and a mono-carboxylic acid salt of polyol or sugar. The solution is stable and turns into a gel within a tem-perature range from 20 to 70° C. The gel has a cosmetically acceptable consistency for providing a mechanical support to surrounding soft tissues once injected therein. The composition can thus be used as filler for soft tissue augmentation and reconstructive surgery.
    Type: Application
    Filed: October 23, 2003
    Publication date: March 11, 2004
    Inventors: Eric Andre Desrosiers, Abdellatif Chenite, Cyril Chaput, Matthew Shive
  • Publication number: 20030199615
    Abstract: The present invention relates to self-setting compositions consisting in admixed liquid and solid components enable the formation of hardened bio-materials having a broad range of properties and performances. The present invention proposes a) a thermo-sensitive self-gelling liquid component, being water-based, comprising at least a polycationic and a phosphate source, wherein the liquid component is a thermo-gelling solution at a pH ranging from 6.5 to 7.4; b) a powder component consisting in at least two calcium phosphate sources. The preferred calcium phosphate source includes apatites, tricalcium phosphates, tetracalcium phosphates and dicalcium phosphates. Both solid and liquid components are admixed to form a flowable slurry that sets in situ into a hardened calcium phosphate based bio-material.
    Type: Application
    Filed: November 22, 2002
    Publication date: October 23, 2003
    Inventors: Cyril Chaput, Anabelle Rodrigues El Zein
  • Publication number: 20030129730
    Abstract: In accordance with the present invention there is provided a new composition and method for chemically modifying chitosan, including N-substituting or N-cross-linking, under homogeneous conditions by providing neutral aqueous chitosan solutions with enhanced reactivity. The method comprises the steps of i) preparing a clear aqueous solution of chitosan, said solution comprising 0.1 to 10% by weight of a chitosan, and 0.1 to 20% by weight of at least one buffering agent having a pKa between 6.0 and 7.6, said solution having a pH ranging from 6.8 to 7.2; and ii) dissolving homogeneously at least one reagent into the solution of step a), said reagent being reactive toward amine groups of chitosan; and said reagent being at a concentration from 0.01 to 10% by weight. The chitosan in the aqueous solution is chemically modified or cross-linked by a selective substitution on the amino group of chitosan.
    Type: Application
    Filed: November 15, 2002
    Publication date: July 10, 2003
    Inventors: Abdellatif Chenite, Mohammed Berrada, Cyril Chaput, Fouad Dabbarh, Amine Selmani
  • Patent number: 6344488
    Abstract: The present invention relates a temperature-controlled pH-dependant formation of ionic polysaccharide gels, such as chitosan/organo-phosphate aqueous systems, and methods of preparation thereof. While chitosan aqueous solutions are pH-dependant gelating systems, the addition of a mono-phosphate dibasic salt of polyol or sugar to a chitosan aqueous solutions leads to further temperature-controlled pH-dependant gelation. Solid organo-phosphate salts (1-20% w/v) are added and dissolved at low temperature (10° C.) within 0.5 to 4.0% w/v chitosan in aqueous acidic solutions. Aqueous chitosan/organo-phosphate solutions are initially stored at low temperatures (4° C.), then endothermally gelated within the temperature range of 30 to 60° C. Chitosan/organo-phosphate solutions rapidly turn into gels at the desired gelation temperature. Gelation can be ex vivo within any receivers or molds, or in situ in animals or humans (in vivo) so as to fill a tissue defect or cavity.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: February 5, 2002
    Assignee: Bio Syntech
    Inventors: Abdellatif Chenite, Cyril Chaput, Christele Combes, Amine Selmani, Fayrouze Jalal